Biosensors & Smart Diagnostic Devices
The U.S. biosensors and smart diagnostic devices market is growing with rising demand for continuous health monitoring, rapid testing, and connected diagnostic technologies. Our research provides actionable insights into market size, technology adoption, competitive developments, and investment opportunities across wearable biosensors, electrochemical sensors, point-of-care platforms, and intelligent diagnostic systems.
The U.S. Reusable Biosensors Market is projected to grow from USD 8.75 billion in 2025 to USD 26.46 billion by 2035 at an 11.70% CAGR, supported by long-duration sensing, remote monitoring, chronic disease management, and reusable diagnostic platforms.
Read Report Details
The U.S. Disposable Biosensors Market is projected to grow from USD 8.20 billion in 2025 to USD 22.56 billion by 2035 at a 10.65% CAGR, supported by rapid CGM adoption, decentralized diagnostics, point-of-care testing, and next-generation wearable biosensors.
Read Report Details
The U.S. Minimally Invasive Biosensors Market is projected to expand from USD 8.20 billion in 2025 to USD 32.45 billion by 2035, supported by rapid CGM adoption, minimally invasive sensor innovation, connected diabetes management, implantable biosensors, and emerging multi-analyte monitoring platforms.
Read Report Details
The U.S. Non-Invasive Biosensors Market is projected to grow from USD 4.05 billion in 2025 to USD 13.20 billion by 2035 at a 12.54% CAGR, driven by wearable sensing, remote monitoring, optical biosensors, and continuous patient surveillance.
Read Report Details
The U.S. Implantable Biosensors Market is projected to grow from USD 3.18 billion in 2025 to USD 13.79 billion by 2035 at a 15.80% CAGR, driven by continuous cardiac monitoring, implantable glucose sensing, closed-loop neuromodulation, hemodynamic monitoring and smart implants.
Read Report Details
The U.S. Wearable Biosensors Market is projected to grow from USD 5.28 billion in 2025 to USD 19.92 billion by 2035 at a 14.20% CAGR, supported by continuous glucose monitoring, wearable ECG, multimodal sensing, and remote patient monitoring.
Read Report Details
The U.S. Digital Diagnostic Devices Market is projected to grow from USD 27.80 billion in 2025 to USD 84.81 billion by 2035 at an 11.80% CAGR, driven by AI-enabled diagnostics, connected devices, digital imaging, point-of-care testing, and decentralized diagnostic workflows.
Read Report Details
The U.S. Connected Diagnostic Devices Market is projected to grow from USD 18.60 billion in 2025 to USD 65.12 billion by 2035 at a 13.35% CAGR, driven by connected diagnostics, remote monitoring, AI-enabled devices, and decentralized care.
Read Report Details
The U.S. Smart Diagnostic Devices Market is projected to grow from USD 27.85 billion in 2025 to USD 97.25 billion by 2035, driven by AI-enabled diagnostics, connected point-of-care testing, wearable biosensors, smart imaging, and decentralized healthcare.
Read Report Details
The U.S. Medical Biosensors Market is projected to expand from USD 14.85 billion in 2025 to USD 49.96 billion by 2035 at a 12.90% CAGR, driven by continuous glucose monitoring, wearable biosensors, decentralized diagnostics, and connected chronic disease management.
Read Report Details